Stephanie Monlezun

1 Patent

• US124471592025

  3β-(4-methoxybenzyloxy)pregn-5-en-20-one for Use in the Treatment of Cannabinoids-related Disorders

  UNIVERSITE DE BORDEAUX

  0 cites